EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework‐8 Nanoparticles

Nicola di Nicola iD, Luca Giacchi iD, Marco Vandone iD, Marcello Crucianelli iD, Leonardo Guidoni iD, Valentina Colombo iD, Nadia Rucci iD, Andrea Lazzarini iD

ChemPhysChem · 2025

DOI: 10.1002/cphc.202401128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemPhysChem, 2025. Verfasst von Nicola di Nicola und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical and Chemical Sciences (DSFC), University of L'Aquila, Via Vetoio ("A.C. De Meis" building), 67100, L'Aquila, Italy. Hauptthemen laut MEDLINE: Zeolites, Lidocaine, Breast Neoplasms, Imidazoles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research (MUR) National Innovation Ecosystem, European Union- NextGenerationEU, territorial leaders in R&D.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this article is to use zeolitic imidazolate framework‐8 (ZIF‐8) metal–organic frameworks (MOFs) as drug delivery system for lidocaine, a local anesthetic with recently discovered antitumoral effects, in particular for the early‐stage treatment of breast cancer. A previously optimized ZIF‐8 synthetic method is employed, and the prepared material is deeply characterized with X‐ray powder diffraction (XRPD), surface area analysis, scanning electron microscopy (SEM), and thermogravimetric analysis (TGA). After confirming the successful synthetic outcomes, a tailored loading procedure is developed to incorporate lidocaine within the ZIF‐8 pores. The effectiveness of this loading process is verified using UV–Vis spectroscopy and TGA, while SEM and attenuated total reflectance‐mid infrared spectroscopy further confirms the presence of lidocaine within the MOF pores. Afterwards, the pH‐responsive drug release by dialyzing the lidocaine@ZIF‐8 sample is tested either at physiological or at weakly acid pH values by UV spectroscopy on the dialysis solutions. Finally, the MDA‐MB‐231 breast cancer cells viability of lidocaine@ZIF‐8 system is tested and compared with the free drug and the MOF alone, confirming its significant capabilities in the reduction of cells viability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZeolitesLidocaineBreast NeoplasmsImidazolesNanoparticlesMetal-Organic FrameworksDrug CarriersAntineoplastic AgentsHumansFemaleCell Line, TumorCell SurvivalDrug LiberationDrug Delivery SystemsHydrogen-Ion Concentration

Stichwörter der Autor:innen

ZIF‐8 nanoparticlesanticancer applicationlidocainepH‐regulated deliverytargeted delivery

Substanzen

ZeolitesLidocaineImidazolesMetal-Organic FrameworksDrug CarriersAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Physical and Chemical Sciences (DSFC), University of L'Aquila, Via Vetoio ("A.C. De Meis" building), 67100, L'Aquila, Italy.
  • UdR INSTM of L'Aquila, University of L'Aquila, Via Vetoio ("A.C. De Meis" building), 67100, L'Aquila, Italy.
  • Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, Via Vetoio ("A.C. De Meis" building), 67100, L'Aquila, Italy.
  • Department of Chemistry and UdR INSTM of Milano, University of Milano, Via C. Golgi 19, 67100, Milano, Italy.

ORCID-Profile: Nicola di Nicola, Luca Giacchi, Marco Vandone, Marcello Crucianelli, Leonardo Guidoni, Valentina Colombo, Nadia Rucci, Andrea Lazzarini

Förderung

  • Research (MUR) National Innovation Ecosystem
  • European Union- NextGenerationEU
  • territorial leaders in R&D

Zitieren

APA

di Nicola, N., Giacchi, L., Vandone, M., Crucianelli, M., Guidoni, L., Colombo, V., Rucci, N., & Lazzarini, A. (2025). Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework‐8 Nanoparticles. ChemPhysChem. https://doi.org/10.1002/cphc.202401128

Vancouver

di Nicola N, Giacchi L, Vandone M, Crucianelli M, Guidoni L, Colombo V, et al. Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework‐8 Nanoparticles. ChemPhysChem. 2025. doi:10.1002/cphc.202401128

BibTeX
@article{diNicola2025,
  author = {di Nicola, Nicola and Giacchi, Luca and Vandone, Marco and Crucianelli, Marcello and Guidoni, Leonardo and Colombo, Valentina and Rucci, Nadia and Lazzarini, Andrea},
  title = {Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework‐8 Nanoparticles},
  journal = {ChemPhysChem},
  year = {2025},
  doi = {10.1002/cphc.202401128}
}
Kostenlos starten →